(2021). Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification? Annals of Rehabilitation Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?"
Annals of Rehabilitation Medicine 2021.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?"
Annals of Rehabilitation Medicine, 2021.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.